跳至主要内容
临床试验/NCT01169727
NCT01169727已完成不适用

Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand

AstraZeneca1 个研究点 分布在 1 个国家目标入组 684 人开始时间: 2010年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
684
试验地点
1
主要终点
Changes in PEF and overall CCQ score

研究概览

简要总结

The purpose of this study is to evaluate health status of uncontrolled Chronic Obstructive Pulmonary Disease (COPD) patients in response to treatments in clinical practice.

详细描述

MC MD

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
41 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of informed consent prior to any study specific procedures
  • Male or non-pregnant female aged >40 years
  • A clinical diagnosis of COPD with FEV1/ FVC <0.70 and require combination or modified therapy
  • Smoke > 10 Pack Year

排除标准

  • Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
  • Participation in a clinical study (precluding non-interventional study or registry) during the last 3 months

结局指标

主要结局

Changes in PEF and overall CCQ score

时间窗: between the first visit and after 12 (plus or minus 1) weeks

次要结局

  • Difference of the changes of PEF and overall CCQ score comparing between various treatments(between the first visit and after 12 (plus or minus 1) weeks)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验